HAMPTON, N.J. (AP) _ Celldex Therapeutics Inc. (CLDX) on Tuesday reported a loss of $17.2 million in its first quarter.
On a per-share basis, the Hampton, New Jersey-based company said it had a loss of $1.40. Losses, adjusted for asset impairment costs and non-recurring costs, came to $1.13 per share.
The biopharmaceutical company posted revenue of $1.4 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit $3.84. A year ago, they were trading at $11.74.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLDX at https://www.zacks.com/ap/CLDX